143 related articles for article (PubMed ID: 10660852)
1. Pharmacokinetics of cefpirome in critically ill patients with renal failure treated by continuous veno-venous hemofiltration.
Van der Werf TS; Fijen JW; Van de Merbel NC; Spanjersberg R; Möller AV; Ligtenberg JJ; Tulleken JE; Zijlstra JG; Stegeman CA
Intensive Care Med; 1999 Dec; 25(12):1427-31. PubMed ID: 10660852
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefpirome during continuous venovenous hemofiltration: rationale for an 8-hour dosing interval.
Banyai M; Thalhammer F; El-Menyawi I; Heinz G; Traunmüller F; Siostrzonek P
Clin Pharmacol Ther; 2000 Apr; 67(4):368-72. PubMed ID: 10801245
[TBL] [Abstract][Full Text] [Related]
3. Low cefpirome levels during twice daily dosing in critically ill septic patients: pharmacokinetic modelling calls for more frequent dosing.
Lipman J; Wallis SC; Rickard CM; Fraenkel D
Intensive Care Med; 2001 Feb; 27(2):363-70. PubMed ID: 11396280
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
[TBL] [Abstract][Full Text] [Related]
5. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration.
Heering P; Morgera S; Schmitz FJ; Schmitz G; Willers R; Schultheiss HP; Strauer BE; Grabensee B
Intensive Care Med; 1997 Mar; 23(3):288-96. PubMed ID: 9083231
[TBL] [Abstract][Full Text] [Related]
6. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ
Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH).
van der Werf TS; Mulder PO; Zijlstra JG; Uges DR; Stegeman CA
Intensive Care Med; 1997 Aug; 23(8):873-7. PubMed ID: 9310805
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing.
Bouman CS; van Kan HJ; Koopmans RP; Korevaar JC; Schultz MJ; Vroom MB
Intensive Care Med; 2006 Dec; 32(12):2013-9. PubMed ID: 17043848
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
Boereboom FT; Ververs FF; Blankestijn PJ; Savelkoul TJ; van Dijk A
Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
[TBL] [Abstract][Full Text] [Related]
10. Removal of piperacillin in critically ill patients undergoing continuous venovenous hemofiltration.
Capellier G; Cornette C; Boillot A; Guinchard C; Jacques T; Blasco G; Barale F
Crit Care Med; 1998 Jan; 26(1):88-91. PubMed ID: 9428548
[TBL] [Abstract][Full Text] [Related]
11. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration.
Hansen E; Bucher M; Jakob W; Lemberger P; Kees F
Intensive Care Med; 2001 Feb; 27(2):371-5. PubMed ID: 11396281
[TBL] [Abstract][Full Text] [Related]
13. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.
Bellomo R; Tipping P; Boyce N
Crit Care Med; 1993 Apr; 21(4):522-6. PubMed ID: 8472571
[TBL] [Abstract][Full Text] [Related]
14. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
Muhl E; Martens T; Iven H; Rob P; Bruch HP
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
16. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
Liu Y; Ouyang B; Chen J; Chen M; Ma J; Wu J; Huang S; Li L; Liu Z; Guan X
Chin Med J (Engl); 2014; 127(10):1827-32. PubMed ID: 24824239
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
[TBL] [Abstract][Full Text] [Related]
18. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital.
Chuasuwan A; Gojaseni P; Chittinandana A
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459
[TBL] [Abstract][Full Text] [Related]
19. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
Malone RS; Fish DN; Abraham E; Teitelbaum I
Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
